Univercells announced the acquisition of SynHelix in January 2022, SynHelix is now part of Quantoom Biosciences, a Univercells company.
SynHelix team is devoted to the development of the most robust and scalable DNA synthesis technology using a specifically engineered high-perfomance enzyme. To know more
